• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Evonik

    Health Canada Approves Slenyto for Insomnia in Autistic Childrene

    PR NEWSWIRE

    Neurim Pharmaceuticals gets EU approval for pediatric melatonin

    PR NEWSWIRE

    EMA Committee Recommends Slenyto For Insomnia In Children With NGDs

    PHARMABIZ

    Neurim Gets CHMP Opinion On SLENYTO For Insomnia In Children With NGDs

    PR NEWSWIRE

    Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.